Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Motor Activity 19 Polycystic Ovary Syndrome 10 Prostatic Neoplasms 7 Breast Neoplasms 6 Neoplasms 5 Colorectal Neoplasms 4 Insulin Resistance 3 Lung Neoplasms 2 Fatigue 2 Esophageal Neoplasms 2 Cardiotoxicity 2 Stomach Neoplasms 1 Rectal Neoplasms 1 Primary Dysautonomias 1 Pediatric Brain Tumor 1 Ovarian Neoplasms 1 Multiple Endocrine Neoplasia Type 1 1 Lymphoma, Follicular 1 Lupus Erythematosus, Systemic 1 Inflammation 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Disease 1 Diabetes Mellitus, Type 1 1 Chemotherapy-Related Cognitive Impairment 1 Cardiovascular Diseases 1 Carcinoma, Hepatocellular 1 Cachexia 1

Interventions

fludarabine phosphate 15 Cyclophosphamide 15 Peripheral Blood Stem Cell Transplantation 13 Cyclosporine 12 Whole-Body Irradiation 10 Filgrastim 10 Mycophenolic Acid 9 Busulfan 8 Antilymphocyte Serum 7 Radiotherapy 5 Methylprednisolone 5 Melphalan 5 Therapeutics 4 Psychiatric Rehabilitation 4 Methotrexate 4 Exercise 4 Etoposide 4 Cord Blood Stem Cell Transplantation 4 Blood Specimen Collection 4 fludarabine 3 Rituximab 3 Prednisone 3 Granulocyte Colony-Stimulating Factor 3 Dexamethasone 3 Aprepitant 3 Analgesia 3 plerixafor 2 Tacrolimus 2 Standard of Care 2 Ondansetron 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Lymphoma, Follicular × High-Intensity Interval Training × Clear all

NCT04902092 2023-10-23

BEAT

Monash University

Phase NA Completed

Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡